Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 1,929 shares at $8.89 ($17K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
Open-market sale of $17k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADPT | SELL | 2026-02-06 | $40K | — | Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |